 Barry Rumack
Concepts (684)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acetaminophen | 64 | 2024 | 244 | 9.790 |
Why?
| | Analgesics, Non-Narcotic | 19 | 2024 | 116 | 6.630 |
Why?
| | Chemical and Drug Induced Liver Injury | 30 | 2024 | 136 | 5.760 |
Why?
| | Acetylcysteine | 34 | 2024 | 147 | 4.890 |
Why?
| | Drug Overdose | 26 | 2024 | 293 | 4.380 |
Why?
| | Antidotes | 23 | 2024 | 126 | 2.930 |
Why?
| | Poisoning | 25 | 2012 | 109 | 1.340 |
Why?
| | Nomograms | 4 | 2019 | 48 | 1.190 |
Why?
| | Antiemetics | 1 | 2024 | 34 | 0.950 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2023 | 246 | 0.940 |
Why?
| | Poisons | 1 | 2023 | 21 | 0.910 |
Why?
| | Poison Control Centers | 16 | 2012 | 84 | 0.840 |
Why?
| | Alanine Transaminase | 8 | 2022 | 151 | 0.810 |
Why?
| | Canada | 5 | 2023 | 338 | 0.770 |
Why?
| | End Stage Liver Disease | 1 | 2021 | 73 | 0.710 |
Why?
| | Liver | 23 | 2023 | 1803 | 0.660 |
Why?
| | Humans | 200 | 2024 | 118251 | 0.630 |
Why?
| | Cyanides | 9 | 1993 | 46 | 0.560 |
Why?
| | Anaphylaxis | 1 | 2018 | 146 | 0.530 |
Why?
| | Decision Support Techniques | 1 | 2019 | 364 | 0.520 |
Why?
| | Nonprescription Drugs | 4 | 2008 | 67 | 0.480 |
Why?
| | Free Radical Scavengers | 2 | 2012 | 88 | 0.450 |
Why?
| | Sodium Nitrite | 7 | 1997 | 36 | 0.440 |
Why?
| | Mushroom Poisoning | 4 | 2019 | 5 | 0.440 |
Why?
| | Charcoal | 12 | 1999 | 23 | 0.430 |
Why?
| | Adult | 71 | 2023 | 31324 | 0.410 |
Why?
| | Iatrogenic Disease | 1 | 2012 | 49 | 0.410 |
Why?
| | Plant Poisoning | 6 | 1988 | 9 | 0.390 |
Why?
| | Retrospective Studies | 14 | 2023 | 12929 | 0.390 |
Why?
| | Medication Errors | 1 | 2012 | 91 | 0.390 |
Why?
| | Adolescent | 42 | 2020 | 18364 | 0.380 |
Why?
| | Male | 86 | 2022 | 57474 | 0.370 |
Why?
| | Environmental Exposure | 7 | 2012 | 397 | 0.360 |
Why?
| | Protective Agents | 2 | 2020 | 41 | 0.350 |
Why?
| | Nasal Decongestants | 1 | 2008 | 9 | 0.340 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2023 | 38 | 0.340 |
Why?
| | Multicenter Studies as Topic | 3 | 2024 | 252 | 0.340 |
Why?
| | Common Cold | 1 | 2008 | 11 | 0.340 |
Why?
| | Antitussive Agents | 1 | 2008 | 7 | 0.340 |
Why?
| | Time Factors | 21 | 2021 | 6368 | 0.330 |
Why?
| | Alcohol Drinking | 2 | 2012 | 651 | 0.330 |
Why?
| | Nitrites | 5 | 1989 | 80 | 0.320 |
Why?
| | Cough | 1 | 2008 | 102 | 0.320 |
Why?
| | Hyperbaric Oxygenation | 5 | 1991 | 39 | 0.290 |
Why?
| | Hepatocytes | 4 | 2022 | 204 | 0.290 |
Why?
| | Female | 73 | 2022 | 61261 | 0.280 |
Why?
| | Child | 41 | 2023 | 19033 | 0.280 |
Why?
| | Hydrogen Sulfide | 3 | 1997 | 40 | 0.280 |
Why?
| | Infant | 36 | 2012 | 8254 | 0.260 |
Why?
| | Child, Preschool | 38 | 2014 | 9448 | 0.260 |
Why?
| | Young Adult | 9 | 2023 | 10731 | 0.260 |
Why?
| | Databases, Factual | 6 | 2019 | 1196 | 0.260 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 3 | 2020 | 155 | 0.250 |
Why?
| | Administration, Oral | 10 | 2019 | 753 | 0.250 |
Why?
| | Ibuprofen | 3 | 1992 | 76 | 0.250 |
Why?
| | Ethanol | 9 | 2012 | 574 | 0.250 |
Why?
| | Potassium Cyanide | 3 | 1989 | 18 | 0.250 |
Why?
| | Pain | 2 | 2020 | 736 | 0.250 |
Why?
| | Infusions, Intravenous | 5 | 2019 | 379 | 0.240 |
Why?
| | Plants, Medicinal | 3 | 1989 | 17 | 0.240 |
Why?
| | Risk Assessment | 3 | 2024 | 3043 | 0.240 |
Why?
| | Drug Information Services | 6 | 1988 | 9 | 0.240 |
Why?
| | Aspirin | 8 | 1989 | 334 | 0.230 |
Why?
| | Imines | 1 | 2022 | 8 | 0.220 |
Why?
| | Alcoholism | 5 | 2000 | 714 | 0.220 |
Why?
| | Free Radicals | 2 | 1993 | 104 | 0.220 |
Why?
| | Suicide, Attempted | 12 | 1990 | 313 | 0.210 |
Why?
| | Benzoquinones | 1 | 2022 | 44 | 0.210 |
Why?
| | Salicylates | 7 | 1989 | 31 | 0.210 |
Why?
| | Exchange Transfusion, Whole Blood | 2 | 1992 | 18 | 0.200 |
Why?
| | Ipecac | 6 | 1990 | 8 | 0.200 |
Why?
| | Thiosulfates | 4 | 1993 | 19 | 0.200 |
Why?
| | Liver Function Tests | 3 | 2012 | 107 | 0.190 |
Why?
| | Time-to-Treatment | 2 | 2019 | 148 | 0.190 |
Why?
| | Physostigmine | 6 | 1983 | 10 | 0.190 |
Why?
| | Seizures | 6 | 1991 | 345 | 0.190 |
Why?
| | Coma | 9 | 1990 | 32 | 0.190 |
Why?
| | Hypotension | 5 | 1989 | 119 | 0.190 |
Why?
| | Cytochrome P-450 CYP2E1 Inhibitors | 1 | 2019 | 5 | 0.180 |
Why?
| | Acute Kidney Injury | 4 | 2020 | 705 | 0.180 |
Why?
| | United States | 15 | 2012 | 12488 | 0.180 |
Why?
| | Emergencies | 6 | 1989 | 152 | 0.180 |
Why?
| | Ambulatory Care | 1 | 2023 | 480 | 0.180 |
Why?
| | Electric Power Supplies | 3 | 1992 | 48 | 0.170 |
Why?
| | Metabolome | 1 | 2022 | 288 | 0.170 |
Why?
| | Agaricales | 1 | 2018 | 3 | 0.170 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 690 | 0.170 |
Why?
| | Smoke Inhalation Injury | 2 | 1989 | 19 | 0.170 |
Why?
| | Plants, Toxic | 3 | 1988 | 28 | 0.170 |
Why?
| | Fever | 2 | 2000 | 283 | 0.170 |
Why?
| | Emetics | 5 | 1984 | 7 | 0.170 |
Why?
| | Magnesium | 3 | 1988 | 150 | 0.160 |
Why?
| | Administration, Intravenous | 2 | 2016 | 135 | 0.160 |
Why?
| | Foreign Bodies | 3 | 1992 | 98 | 0.160 |
Why?
| | Drug Monitoring | 1 | 1999 | 185 | 0.160 |
Why?
| | Histamine Antagonists | 1 | 2018 | 19 | 0.160 |
Why?
| | Excipients | 2 | 1988 | 50 | 0.160 |
Why?
| | Cathartics | 4 | 1992 | 11 | 0.160 |
Why?
| | Glutathione | 5 | 2022 | 324 | 0.150 |
Why?
| | Sex Factors | 5 | 2022 | 1765 | 0.150 |
Why?
| | Information Systems | 4 | 2010 | 66 | 0.150 |
Why?
| | Dermatitis, Contact | 2 | 1989 | 20 | 0.150 |
Why?
| | Prothrombin Time | 3 | 1993 | 35 | 0.150 |
Why?
| | Middle Aged | 22 | 2023 | 27510 | 0.150 |
Why?
| | Phenytoin | 3 | 2004 | 14 | 0.150 |
Why?
| | Hospital Mortality | 1 | 2021 | 811 | 0.140 |
Why?
| | Occupational Diseases | 2 | 1990 | 136 | 0.140 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 277 | 0.140 |
Why?
| | Hospitals | 1 | 2021 | 600 | 0.140 |
Why?
| | Drug Interactions | 4 | 2019 | 351 | 0.140 |
Why?
| | Amygdalin | 3 | 1986 | 3 | 0.130 |
Why?
| | Toxicology | 3 | 1990 | 35 | 0.130 |
Why?
| | Cimetidine | 1 | 1995 | 16 | 0.130 |
Why?
| | Patient Selection | 1 | 2019 | 670 | 0.130 |
Why?
| | 3,4-Methylenedioxyamphetamine | 2 | 1987 | 2 | 0.130 |
Why?
| | Amphetamines | 2 | 1987 | 4 | 0.130 |
Why?
| | Arsenic Poisoning | 2 | 1989 | 8 | 0.130 |
Why?
| | Animals | 24 | 2023 | 33152 | 0.120 |
Why?
| | Mice, Inbred C57BL | 5 | 2023 | 4887 | 0.120 |
Why?
| | Drug Administration Schedule | 4 | 2014 | 734 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2018 | 9319 | 0.120 |
Why?
| | Cohort Studies | 2 | 2018 | 5078 | 0.120 |
Why?
| | Aspartate Aminotransferases | 6 | 2002 | 94 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1857 | 0.120 |
Why?
| | Riots | 1 | 1993 | 2 | 0.120 |
Why?
| | Psychophysiologic Disorders | 1 | 1993 | 11 | 0.120 |
Why?
| | Risk Factors | 4 | 2019 | 8958 | 0.120 |
Why?
| | Societies | 5 | 2012 | 42 | 0.120 |
Why?
| | Acute Disease | 8 | 1993 | 933 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 808 | 0.110 |
Why?
| | Risk | 5 | 2009 | 849 | 0.110 |
Why?
| | Carbon Tetrachloride | 1 | 1993 | 9 | 0.110 |
Why?
| | Hydrocarbons, Halogenated | 1 | 1993 | 5 | 0.110 |
Why?
| | Prospective Studies | 11 | 2020 | 6443 | 0.110 |
Why?
| | Methemoglobin | 3 | 1989 | 22 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2659 | 0.110 |
Why?
| | Xenobiotics | 1 | 2012 | 25 | 0.110 |
Why?
| | Phenobarbital | 4 | 2004 | 18 | 0.110 |
Why?
| | Prognosis | 3 | 2019 | 3424 | 0.110 |
Why?
| | Electrolytes | 2 | 1990 | 59 | 0.110 |
Why?
| | United States Food and Drug Administration | 2 | 2012 | 174 | 0.110 |
Why?
| | Life Change Events | 1 | 1993 | 132 | 0.110 |
Why?
| | Warfarin | 1 | 1993 | 139 | 0.110 |
Why?
| | Digestive System | 1 | 1992 | 29 | 0.110 |
Why?
| | Hydrocarbons | 2 | 1986 | 34 | 0.110 |
Why?
| | Drug Dosage Calculations | 1 | 2012 | 21 | 0.100 |
Why?
| | Vascular Headaches | 1 | 1991 | 1 | 0.100 |
Why?
| | Fluoride Poisoning | 1 | 1991 | 4 | 0.100 |
Why?
| | Bromocriptine | 1 | 1991 | 28 | 0.100 |
Why?
| | Carbon Tetrachloride Poisoning | 1 | 1991 | 3 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1787 | 0.100 |
Why?
| | Sympathomimetics | 1 | 1991 | 26 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2262 | 0.100 |
Why?
| | Gas Poisoning | 2 | 1993 | 5 | 0.100 |
Why?
| | Magnesium Sulfate | 2 | 1988 | 18 | 0.100 |
Why?
| | Incidence | 1 | 2018 | 2413 | 0.100 |
Why?
| | Methemoglobinemia | 3 | 1986 | 13 | 0.100 |
Why?
| | Hydroxocobalamin | 2 | 1993 | 26 | 0.100 |
Why?
| | Methanol | 1 | 1991 | 35 | 0.100 |
Why?
| | Gastric Lavage | 6 | 1992 | 9 | 0.100 |
Why?
| | Information Services | 3 | 1990 | 45 | 0.100 |
Why?
| | Vancomycin | 1 | 1992 | 79 | 0.100 |
Why?
| | Therapeutic Irrigation | 1 | 1990 | 67 | 0.090 |
Why?
| | Pyridoxine | 1 | 1990 | 26 | 0.090 |
Why?
| | Sulfates | 1 | 1990 | 47 | 0.090 |
Why?
| | Naloxone | 4 | 1985 | 98 | 0.090 |
Why?
| | Alcoholic Intoxication | 2 | 1988 | 61 | 0.090 |
Why?
| | Substance-Related Disorders | 4 | 1987 | 967 | 0.090 |
Why?
| | Pregnancy Complications | 2 | 1989 | 447 | 0.090 |
Why?
| | Liver Diseases | 4 | 2002 | 282 | 0.090 |
Why?
| | Amphotericin B | 1 | 1990 | 30 | 0.090 |
Why?
| | Interior Design and Furnishings | 1 | 1990 | 4 | 0.090 |
Why?
| | Methylene Chloride | 1 | 1990 | 4 | 0.090 |
Why?
| | Isoniazid | 1 | 1990 | 53 | 0.090 |
Why?
| | Hydrofluoric Acid | 2 | 1989 | 8 | 0.090 |
Why?
| | Facility Design and Construction | 1 | 1990 | 12 | 0.090 |
Why?
| | Hospitalization | 2 | 2019 | 1778 | 0.090 |
Why?
| | Phenelzine | 2 | 1987 | 4 | 0.090 |
Why?
| | Societies, Scientific | 1 | 1990 | 49 | 0.090 |
Why?
| | Hydrocarbons, Chlorinated | 1 | 1990 | 20 | 0.090 |
Why?
| | Rodenticides | 1 | 1989 | 3 | 0.090 |
Why?
| | 4-Hydroxycoumarins | 1 | 1989 | 4 | 0.090 |
Why?
| | Penicillamine | 5 | 1986 | 24 | 0.090 |
Why?
| | Kinetics | 12 | 1987 | 1623 | 0.090 |
Why?
| | Mycoses | 1 | 1990 | 68 | 0.090 |
Why?
| | Half-Life | 7 | 1992 | 147 | 0.090 |
Why?
| | Sodium Compounds | 1 | 1989 | 3 | 0.090 |
Why?
| | Arsenites | 1 | 1989 | 4 | 0.090 |
Why?
| | Eucalyptus | 1 | 1989 | 5 | 0.090 |
Why?
| | Iron | 1 | 1991 | 247 | 0.090 |
Why?
| | Plant Oils | 1 | 1989 | 28 | 0.090 |
Why?
| | Thyroxine | 2 | 1987 | 62 | 0.090 |
Why?
| | Chlorambucil | 1 | 1988 | 8 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2855 | 0.080 |
Why?
| | Trees | 1 | 1989 | 67 | 0.080 |
Why?
| | Construction Materials | 2 | 1986 | 14 | 0.080 |
Why?
| | Writing | 1 | 1990 | 88 | 0.080 |
Why?
| | Alprazolam | 1 | 1988 | 6 | 0.080 |
Why?
| | Perfume | 1 | 1988 | 3 | 0.080 |
Why?
| | Botany | 1 | 1988 | 2 | 0.080 |
Why?
| | Captopril | 1 | 1988 | 12 | 0.080 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 68 | 0.080 |
Why?
| | Critical Pathways | 1 | 2009 | 79 | 0.080 |
Why?
| | Antioxidants | 2 | 1993 | 564 | 0.080 |
Why?
| | Vomiting | 3 | 1988 | 123 | 0.080 |
Why?
| | Chewing Gum | 1 | 1988 | 8 | 0.080 |
Why?
| | Heart Diseases | 1 | 1991 | 340 | 0.080 |
Why?
| | Fabaceae | 1 | 1988 | 7 | 0.080 |
Why?
| | Diflunisal | 1 | 1987 | 2 | 0.080 |
Why?
| | Polyethylene Glycols | 2 | 1990 | 575 | 0.080 |
Why?
| | Sweetening Agents | 1 | 1988 | 52 | 0.080 |
Why?
| | Aged | 8 | 2020 | 19594 | 0.080 |
Why?
| | Zinc | 1 | 1990 | 261 | 0.080 |
Why?
| | Blood Coagulation Disorders | 1 | 1989 | 166 | 0.080 |
Why?
| | Intestinal Absorption | 3 | 1999 | 104 | 0.080 |
Why?
| | Imipramine | 3 | 1979 | 14 | 0.080 |
Why?
| | Medication Systems | 1 | 1987 | 2 | 0.080 |
Why?
| | International System of Units | 1 | 1987 | 2 | 0.080 |
Why?
| | Theophylline | 1 | 1987 | 60 | 0.080 |
Why?
| | Arrhythmias, Cardiac | 3 | 1981 | 277 | 0.080 |
Why?
| | Weights and Measures | 1 | 1987 | 7 | 0.080 |
Why?
| | Fruit | 1 | 1988 | 129 | 0.080 |
Why?
| | Basidiomycota | 1 | 1987 | 22 | 0.070 |
Why?
| | Quinine | 1 | 1987 | 12 | 0.070 |
Why?
| | Mistletoe | 1 | 1986 | 1 | 0.070 |
Why?
| | Pharmacy Service, Hospital | 1 | 1988 | 86 | 0.070 |
Why?
| | Drug Therapy, Combination | 3 | 2002 | 964 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2012 | 1237 | 0.070 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 1987 | 29 | 0.070 |
Why?
| | Blindness | 1 | 1987 | 35 | 0.070 |
Why?
| | Clonidine | 2 | 1983 | 22 | 0.070 |
Why?
| | Xylazine | 1 | 1986 | 6 | 0.070 |
Why?
| | Thiazines | 1 | 1986 | 9 | 0.070 |
Why?
| | Microsomes, Liver | 4 | 1976 | 59 | 0.070 |
Why?
| | Population Surveillance | 4 | 2011 | 413 | 0.070 |
Why?
| | Magnesium Compounds | 1 | 1986 | 2 | 0.070 |
Why?
| | Aluminum Compounds | 1 | 1986 | 7 | 0.070 |
Why?
| | Silicates | 1 | 1986 | 11 | 0.070 |
Why?
| | Boric Acids | 1 | 1986 | 2 | 0.070 |
Why?
| | Atropine | 4 | 1987 | 32 | 0.070 |
Why?
| | Yohimbine | 1 | 1985 | 9 | 0.070 |
Why?
| | Oxidoreductases | 3 | 1986 | 98 | 0.070 |
Why?
| | Epinephrine | 1 | 1987 | 166 | 0.070 |
Why?
| | Guanabenz | 1 | 1985 | 1 | 0.070 |
Why?
| | Guanidines | 1 | 1985 | 37 | 0.070 |
Why?
| | Amitriptyline | 3 | 1983 | 21 | 0.070 |
Why?
| | Pancreatitis | 1 | 1986 | 105 | 0.070 |
Why?
| | Accidents, Home | 5 | 1988 | 32 | 0.070 |
Why?
| | Mice | 4 | 2023 | 15446 | 0.070 |
Why?
| | Gastric Emptying | 1 | 1985 | 40 | 0.070 |
Why?
| | Nicotine | 1 | 1988 | 275 | 0.070 |
Why?
| | Chlorobenzenes | 1 | 1985 | 8 | 0.070 |
Why?
| | Infant, Newborn | 7 | 2008 | 5230 | 0.060 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 1993 | 759 | 0.060 |
Why?
| | Substance Withdrawal Syndrome | 3 | 1985 | 157 | 0.060 |
Why?
| | Marine Toxins | 1 | 1985 | 13 | 0.060 |
Why?
| | Injections, Intravenous | 4 | 1991 | 209 | 0.060 |
Why?
| | Kidney | 3 | 2023 | 1351 | 0.060 |
Why?
| | Bronchodilator Agents | 1 | 1987 | 251 | 0.060 |
Why?
| | Insecticides | 1 | 1985 | 31 | 0.060 |
Why?
| | Naphthalenes | 1 | 1985 | 41 | 0.060 |
Why?
| | Morphinans | 3 | 1973 | 7 | 0.060 |
Why?
| | Lactones | 1 | 1985 | 57 | 0.060 |
Why?
| | Computers | 2 | 1988 | 64 | 0.060 |
Why?
| | Bacterial Toxins | 1 | 1985 | 105 | 0.060 |
Why?
| | Heroin | 1 | 1984 | 19 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2014 | 1937 | 0.060 |
Why?
| | Medical History Taking | 2 | 1999 | 120 | 0.060 |
Why?
| | Deglutition | 1 | 1984 | 62 | 0.060 |
Why?
| | Cyanobacteria | 1 | 1985 | 62 | 0.060 |
Why?
| | Oxidation-Reduction | 2 | 2019 | 935 | 0.060 |
Why?
| | Household Products | 1 | 1983 | 6 | 0.060 |
Why?
| | Ethylene Glycols | 1 | 1983 | 15 | 0.060 |
Why?
| | Copper | 1 | 1984 | 102 | 0.060 |
Why?
| | Talc | 1 | 1982 | 5 | 0.060 |
Why?
| | Online Systems | 1 | 1983 | 25 | 0.060 |
Why?
| | Barbiturates | 2 | 2002 | 5 | 0.060 |
Why?
| | Drug Labeling | 2 | 2000 | 44 | 0.060 |
Why?
| | Cognition Disorders | 1 | 1987 | 528 | 0.060 |
Why?
| | Infant Care | 1 | 1982 | 43 | 0.050 |
Why?
| | Hallucinations | 4 | 1979 | 29 | 0.050 |
Why?
| | Lactates | 1 | 2022 | 86 | 0.050 |
Why?
| | Hemorrhage | 1 | 1986 | 606 | 0.050 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 85 | 0.050 |
Why?
| | Phenylpropanolamine | 3 | 1982 | 3 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2002 | 92 | 0.050 |
Why?
| | Pharmaceutical Preparations | 1 | 1984 | 168 | 0.050 |
Why?
| | Transaminases | 2 | 2014 | 26 | 0.050 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2002 | 54 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2012 | 4521 | 0.050 |
Why?
| | Colorado | 7 | 1992 | 4178 | 0.050 |
Why?
| | Phencyclidine Abuse | 1 | 1980 | 1 | 0.050 |
Why?
| | Stomach | 4 | 1988 | 103 | 0.050 |
Why?
| | Fluid Therapy | 3 | 1988 | 129 | 0.050 |
Why?
| | Pharmacology | 1 | 2000 | 8 | 0.050 |
Why?
| | Activation, Metabolic | 1 | 2019 | 3 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2002 | 184 | 0.040 |
Why?
| | Methapyrilene | 1 | 1979 | 1 | 0.040 |
Why?
| | Salicylamides | 1 | 1979 | 3 | 0.040 |
Why?
| | Psychology, Child | 1 | 1979 | 36 | 0.040 |
Why?
| | Immune System | 1 | 2020 | 181 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 101 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2000 | 964 | 0.040 |
Why?
| | Drug Compounding | 1 | 1999 | 90 | 0.040 |
Why?
| | Pediatrics | 1 | 1987 | 980 | 0.040 |
Why?
| | Digoxin | 2 | 1979 | 27 | 0.040 |
Why?
| | Critical Care | 1 | 1983 | 488 | 0.040 |
Why?
| | Age Factors | 4 | 1999 | 2990 | 0.040 |
Why?
| | Lipids | 1 | 2022 | 591 | 0.040 |
Why?
| | Aminopyridines | 1 | 1979 | 85 | 0.040 |
Why?
| | Evaluation Studies as Topic | 4 | 1988 | 181 | 0.040 |
Why?
| | Cross-Over Studies | 1 | 2019 | 456 | 0.040 |
Why?
| | Mitochondria | 1 | 2023 | 785 | 0.040 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1986 | 1385 | 0.040 |
Why?
| | Heart Arrest | 1 | 1981 | 291 | 0.040 |
Why?
| | Infant, Newborn, Diseases | 2 | 1981 | 106 | 0.040 |
Why?
| | Caustics | 1 | 1977 | 7 | 0.040 |
Why?
| | Child Behavior | 1 | 1979 | 213 | 0.040 |
Why?
| | Metabolic Clearance Rate | 2 | 1987 | 111 | 0.040 |
Why?
| | Fatal Outcome | 1 | 1997 | 286 | 0.040 |
Why?
| | Protein Binding | 3 | 2019 | 1969 | 0.040 |
Why?
| | Calcium Gluconate | 2 | 1989 | 4 | 0.040 |
Why?
| | Pilot Projects | 1 | 2020 | 1405 | 0.030 |
Why?
| | Glutethimide | 2 | 1979 | 2 | 0.030 |
Why?
| | Hypertension | 4 | 1987 | 1199 | 0.030 |
Why?
| | Heart Rate | 3 | 1993 | 729 | 0.030 |
Why?
| | Genetic Variation | 1 | 2020 | 912 | 0.030 |
Why?
| | Ethchlorvynol | 2 | 1979 | 2 | 0.030 |
Why?
| | Central Nervous System | 3 | 1986 | 243 | 0.030 |
Why?
| | Kidney Diseases | 2 | 1992 | 439 | 0.030 |
Why?
| | Isonipecotic Acids | 1 | 1974 | 1 | 0.030 |
Why?
| | Chemistry | 4 | 1985 | 39 | 0.030 |
Why?
| | Clomipramine | 1 | 1974 | 2 | 0.030 |
Why?
| | Dibenzazepines | 1 | 1974 | 4 | 0.030 |
Why?
| | Dopamine | 2 | 1988 | 249 | 0.030 |
Why?
| | Apoptosis | 1 | 2023 | 2461 | 0.030 |
Why?
| | Chemical Phenomena | 4 | 1985 | 82 | 0.030 |
Why?
| | Central Nervous System Diseases | 2 | 1987 | 64 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2262 | 0.030 |
Why?
| | Protein Deficiency | 1 | 1973 | 3 | 0.030 |
Why?
| | Quaternary Ammonium Compounds | 1 | 1974 | 46 | 0.030 |
Why?
| | Parasympatholytics | 1 | 1973 | 14 | 0.030 |
Why?
| | Georgia (Republic) | 1 | 1993 | 2 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1318 | 0.030 |
Why?
| | Gastrointestinal Agents | 1 | 1974 | 58 | 0.030 |
Why?
| | Civil Rights | 1 | 1993 | 10 | 0.030 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1973 | 9 | 0.030 |
Why?
| | Conversion Disorder | 1 | 1993 | 10 | 0.030 |
Why?
| | Diquat | 1 | 1993 | 1 | 0.030 |
Why?
| | Animals, Domestic | 1 | 2012 | 12 | 0.030 |
Why?
| | Pregnancy | 6 | 1989 | 5671 | 0.030 |
Why?
| | Amoxapine | 2 | 1982 | 2 | 0.030 |
Why?
| | Dibenzoxazepines | 2 | 1982 | 2 | 0.030 |
Why?
| | Mercury Poisoning | 2 | 1983 | 6 | 0.030 |
Why?
| | Injections, Intramuscular | 2 | 1986 | 116 | 0.030 |
Why?
| | Drug Combinations | 4 | 1993 | 291 | 0.030 |
Why?
| | Dietary Proteins | 1 | 1973 | 131 | 0.030 |
Why?
| | Treatment Failure | 1 | 1993 | 340 | 0.030 |
Why?
| | Fluorides, Topical | 1 | 1991 | 16 | 0.030 |
Why?
| | Ear Diseases | 1 | 1992 | 14 | 0.030 |
Why?
| | Electrocardiography | 4 | 1983 | 555 | 0.030 |
Why?
| | Accidents | 1 | 1991 | 44 | 0.030 |
Why?
| | Transferrin | 1 | 1991 | 39 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 1982 | 1848 | 0.020 |
Why?
| | Lactoferrin | 1 | 1991 | 28 | 0.020 |
Why?
| | Bicarbonates | 1 | 1991 | 44 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1522 | 0.020 |
Why?
| | Ferritins | 1 | 1991 | 59 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1993 | 499 | 0.020 |
Why?
| | Hemoperfusion | 3 | 1979 | 4 | 0.020 |
Why?
| | Administration, Rectal | 1 | 1990 | 5 | 0.020 |
Why?
| | Zinc Sulfate | 1 | 1990 | 9 | 0.020 |
Why?
| | Urography | 1 | 1990 | 14 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3567 | 0.020 |
Why?
| | Anticoagulants | 2 | 1989 | 555 | 0.020 |
Why?
| | Lactation | 1 | 1991 | 156 | 0.020 |
Why?
| | Physicians | 2 | 1993 | 792 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 1993 | 322 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2018 | 4044 | 0.020 |
Why?
| | Dimercaprol | 2 | 1981 | 7 | 0.020 |
Why?
| | Protective Devices | 1 | 1990 | 27 | 0.020 |
Why?
| | Skin | 4 | 1989 | 657 | 0.020 |
Why?
| | Creatinine | 1 | 1992 | 491 | 0.020 |
Why?
| | Amyl Nitrite | 1 | 1989 | 1 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 1990 | 46 | 0.020 |
Why?
| | Fetal Death | 1 | 1989 | 53 | 0.020 |
Why?
| | Therapeutic Equivalency | 1 | 1989 | 18 | 0.020 |
Why?
| | Carboxyhemoglobin | 1 | 1989 | 6 | 0.020 |
Why?
| | Apnea | 2 | 1986 | 16 | 0.020 |
Why?
| | Cytochrome-B(5) Reductase | 2 | 1986 | 2 | 0.020 |
Why?
| | Arsenic | 1 | 1989 | 39 | 0.020 |
Why?
| | Abortion, Spontaneous | 1 | 1989 | 94 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 1993 | 484 | 0.020 |
Why?
| | Congresses as Topic | 1 | 1990 | 202 | 0.020 |
Why?
| | Tablets | 1 | 1988 | 35 | 0.020 |
Why?
| | Survival Rate | 1 | 2012 | 1716 | 0.020 |
Why?
| | Acidosis | 1 | 1989 | 84 | 0.020 |
Why?
| | Information Centers | 1 | 1988 | 4 | 0.020 |
Why?
| | Tobacco, Smokeless | 1 | 1988 | 9 | 0.020 |
Why?
| | Dogs | 2 | 1987 | 369 | 0.020 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 1989 | 107 | 0.020 |
Why?
| | Salicylic Acid | 1 | 1987 | 8 | 0.020 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1989 | 122 | 0.020 |
Why?
| | Thirst | 1 | 1987 | 5 | 0.020 |
Why?
| | Pulse | 1 | 1987 | 27 | 0.020 |
Why?
| | Bile | 1 | 1987 | 31 | 0.020 |
Why?
| | Saponins | 1 | 1987 | 7 | 0.020 |
Why?
| | Diagnosis, Differential | 2 | 1987 | 1379 | 0.020 |
Why?
| | Cysteamine | 2 | 1978 | 5 | 0.020 |
Why?
| | Maternal-Fetal Exchange | 2 | 1981 | 156 | 0.020 |
Why?
| | Infant, Premature | 2 | 1981 | 479 | 0.020 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 1987 | 10 | 0.020 |
Why?
| | Keratoconjunctivitis | 1 | 1986 | 3 | 0.020 |
Why?
| | Arousal | 1 | 1987 | 156 | 0.020 |
Why?
| | Carrier Proteins | 1 | 1991 | 725 | 0.020 |
Why?
| | Lighting | 1 | 1986 | 25 | 0.020 |
Why?
| | Hemoglobin M | 1 | 1986 | 2 | 0.020 |
Why?
| | Mortality | 1 | 1988 | 297 | 0.020 |
Why?
| | Abdomen, Acute | 1 | 1986 | 19 | 0.020 |
Why?
| | Inactivation, Metabolic | 1 | 1986 | 10 | 0.020 |
Why?
| | NADPH-Ferrihemoprotein Reductase | 1 | 1986 | 11 | 0.020 |
Why?
| | Methylene Blue | 1 | 1986 | 24 | 0.020 |
Why?
| | Electroencephalography | 1 | 1988 | 387 | 0.020 |
Why?
| | Rats | 5 | 1983 | 5339 | 0.020 |
Why?
| | Ditiocarb | 1 | 1986 | 3 | 0.020 |
Why?
| | Ferrocyanides | 1 | 1986 | 4 | 0.020 |
Why?
| | Aminopropionitrile | 1 | 1986 | 3 | 0.020 |
Why?
| | Kaolin | 1 | 1986 | 3 | 0.020 |
Why?
| | Glycerides | 1 | 1986 | 14 | 0.020 |
Why?
| | Aluminum Silicates | 1 | 1986 | 12 | 0.020 |
Why?
| | Thioctic Acid | 1 | 1986 | 8 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1987 | 142 | 0.020 |
Why?
| | Documentation | 1 | 1988 | 170 | 0.020 |
Why?
| | Drug Synergism | 1 | 1987 | 338 | 0.020 |
Why?
| | Carmustine | 1 | 1986 | 47 | 0.020 |
Why?
| | Dioxins | 1 | 1985 | 4 | 0.020 |
Why?
| | Polychlorinated Dibenzodioxins | 1 | 1985 | 6 | 0.020 |
Why?
| | Latex | 1 | 1985 | 12 | 0.020 |
Why?
| | Intubation, Gastrointestinal | 1 | 1986 | 61 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 1987 | 186 | 0.020 |
Why?
| | Triiodothyronine | 1 | 1985 | 43 | 0.020 |
Why?
| | Propylene Glycols | 1 | 1985 | 26 | 0.020 |
Why?
| | Niacinamide | 1 | 1986 | 70 | 0.020 |
Why?
| | Antivenins | 1 | 1986 | 54 | 0.020 |
Why?
| | Respiration | 1 | 1986 | 184 | 0.020 |
Why?
| | Irritants | 1 | 1985 | 41 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 1993 | 482 | 0.020 |
Why?
| | Turpentine | 1 | 1985 | 5 | 0.020 |
Why?
| | Sleep Stages | 1 | 1985 | 60 | 0.020 |
Why?
| | Smoking | 1 | 1993 | 1478 | 0.020 |
Why?
| | Fluorouracil | 1 | 1986 | 150 | 0.020 |
Why?
| | Ivermectin | 1 | 1985 | 10 | 0.020 |
Why?
| | Microcystins | 1 | 1985 | 9 | 0.020 |
Why?
| | Brucella | 1 | 1964 | 2 | 0.020 |
Why?
| | Spheroplasts | 1 | 1964 | 2 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 1988 | 1163 | 0.020 |
Why?
| | Oxygen Inhalation Therapy | 1 | 1986 | 124 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 3 | 1976 | 111 | 0.020 |
Why?
| | Biochemical Phenomena | 1 | 1964 | 10 | 0.020 |
Why?
| | Bradycardia | 1 | 1985 | 49 | 0.020 |
Why?
| | Intestines | 1 | 1988 | 330 | 0.020 |
Why?
| | Data Collection | 1 | 1988 | 652 | 0.020 |
Why?
| | Tachycardia | 2 | 1987 | 48 | 0.020 |
Why?
| | Penicillins | 1 | 1964 | 52 | 0.020 |
Why?
| | Tissue Culture Techniques | 1 | 1964 | 66 | 0.020 |
Why?
| | Arginine | 1 | 1986 | 247 | 0.020 |
Why?
| | Culture Media | 1 | 1964 | 161 | 0.020 |
Why?
| | Doxorubicin | 1 | 1986 | 301 | 0.020 |
Why?
| | Random Allocation | 1 | 1985 | 344 | 0.020 |
Why?
| | Solvents | 1 | 1985 | 118 | 0.020 |
Why?
| | Biochemistry | 1 | 1964 | 40 | 0.020 |
Why?
| | Burns, Chemical | 2 | 1981 | 25 | 0.020 |
Why?
| | Solubility | 1 | 1985 | 235 | 0.020 |
Why?
| | Copper Sulfate | 1 | 1984 | 6 | 0.020 |
Why?
| | Homeostasis | 1 | 1988 | 589 | 0.020 |
Why?
| | Chlorpheniramine | 2 | 1974 | 10 | 0.020 |
Why?
| | Biotransformation | 1 | 1984 | 52 | 0.010 |
Why?
| | Blood Pressure | 2 | 1993 | 1656 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 1983 | 37 | 0.010 |
Why?
| | Glycine | 1 | 1964 | 162 | 0.010 |
Why?
| | Cytoplasm | 1 | 1964 | 269 | 0.010 |
Why?
| | Drug Packaging | 1 | 1984 | 44 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 1986 | 381 | 0.010 |
Why?
| | Bilirubin | 1 | 1984 | 95 | 0.010 |
Why?
| | Mercury Compounds | 1 | 1983 | 3 | 0.010 |
Why?
| | Diuresis | 2 | 1980 | 8 | 0.010 |
Why?
| | Radiography | 2 | 1983 | 860 | 0.010 |
Why?
| | Endotoxins | 1 | 1964 | 234 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1983 | 23 | 0.010 |
Why?
| | Bacteriophages | 1 | 1964 | 76 | 0.010 |
Why?
| | Dextropropoxyphene | 2 | 1980 | 3 | 0.010 |
Why?
| | Mercury | 1 | 1983 | 29 | 0.010 |
Why?
| | Enema | 1 | 1983 | 39 | 0.010 |
Why?
| | Ephedrine | 1 | 1982 | 6 | 0.010 |
Why?
| | Oxides | 1 | 1983 | 42 | 0.010 |
Why?
| | Cytochromes | 2 | 1973 | 8 | 0.010 |
Why?
| | Powders | 1 | 1982 | 37 | 0.010 |
Why?
| | Cysteine | 1 | 1984 | 184 | 0.010 |
Why?
| | Inhalation | 1 | 1982 | 27 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 1992 | 4574 | 0.010 |
Why?
| | History, 20th Century | 1 | 1984 | 281 | 0.010 |
Why?
| | Phagocytosis | 1 | 1964 | 360 | 0.010 |
Why?
| | Gagging | 1 | 1982 | 1 | 0.010 |
Why?
| | Seasons | 1 | 1985 | 461 | 0.010 |
Why?
| | Caffeine | 1 | 1982 | 61 | 0.010 |
Why?
| | Consciousness | 1 | 1982 | 21 | 0.010 |
Why?
| | Lethal Dose 50 | 1 | 1981 | 12 | 0.010 |
Why?
| | Cattle | 1 | 1985 | 974 | 0.010 |
Why?
| | Gluconates | 1 | 1981 | 4 | 0.010 |
Why?
| | Reflex | 1 | 1982 | 64 | 0.010 |
Why?
| | Diarrhea | 1 | 1983 | 180 | 0.010 |
Why?
| | Blood Glucose | 1 | 1991 | 1936 | 0.010 |
Why?
| | Monocytes | 1 | 1964 | 511 | 0.010 |
Why?
| | Down Syndrome | 1 | 1986 | 328 | 0.010 |
Why?
| | Carbamazepine | 1 | 1981 | 19 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2012 | 6541 | 0.010 |
Why?
| | Drug Evaluation | 1 | 1981 | 81 | 0.010 |
Why?
| | Research | 1 | 1964 | 406 | 0.010 |
Why?
| | Esophagus | 1 | 1983 | 237 | 0.010 |
Why?
| | Formaldehyde | 1 | 1981 | 50 | 0.010 |
Why?
| | Selenium | 1 | 1981 | 38 | 0.010 |
Why?
| | Cerebral Hemorrhage | 1 | 1981 | 100 | 0.010 |
Why?
| | Microchemistry | 2 | 1978 | 15 | 0.010 |
Why?
| | Gold | 1 | 1981 | 102 | 0.010 |
Why?
| | Polyurethanes | 1 | 1981 | 37 | 0.010 |
Why?
| | Urea | 1 | 1981 | 77 | 0.010 |
Why?
| | Nurses | 1 | 1983 | 142 | 0.010 |
Why?
| | Furosemide | 1 | 1980 | 35 | 0.010 |
Why?
| | Enzyme Activation | 2 | 1973 | 810 | 0.010 |
Why?
| | Pharmacists | 1 | 1983 | 235 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 2000 | 27 | 0.010 |
Why?
| | Methods | 2 | 1977 | 66 | 0.010 |
Why?
| | Cyclohexanones | 1 | 1979 | 8 | 0.010 |
Why?
| | Oils, Volatile | 1 | 1979 | 6 | 0.010 |
Why?
| | Abortifacient Agents | 1 | 1979 | 5 | 0.010 |
Why?
| | Metabolism | 1 | 2000 | 39 | 0.010 |
Why?
| | Cyclohexanes | 1 | 1979 | 22 | 0.010 |
Why?
| | Phenothiazines | 1 | 1979 | 5 | 0.010 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 1979 | 29 | 0.010 |
Why?
| | Interprofessional Relations | 1 | 1982 | 260 | 0.010 |
Why?
| | Housing | 1 | 1981 | 122 | 0.010 |
Why?
| | Nitrates | 1 | 1979 | 77 | 0.010 |
Why?
| | Calcium | 1 | 1986 | 1151 | 0.010 |
Why?
| | Enuresis | 1 | 1979 | 4 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 1987 | 587 | 0.010 |
Why?
| | Arthritis, Juvenile | 1 | 1979 | 42 | 0.010 |
Why?
| | Microfilming | 1 | 1979 | 1 | 0.010 |
Why?
| | Hemostasis | 1 | 1979 | 67 | 0.010 |
Why?
| | Self Medication | 1 | 1979 | 8 | 0.010 |
Why?
| | Gingival Neoplasms | 1 | 1979 | 10 | 0.010 |
Why?
| | Thiocyanates | 1 | 1979 | 29 | 0.010 |
Why?
| | Valproic Acid | 1 | 1979 | 44 | 0.010 |
Why?
| | Pregnancy Trimester, Third | 1 | 1979 | 69 | 0.010 |
Why?
| | Podophyllin | 1 | 1978 | 2 | 0.010 |
Why?
| | Opioid-Related Disorders | 1 | 1985 | 415 | 0.010 |
Why?
| | Necrosis | 2 | 1979 | 230 | 0.010 |
Why?
| | Alkaloids | 1 | 1978 | 23 | 0.010 |
Why?
| | Software | 1 | 1983 | 566 | 0.010 |
Why?
| | Skin Manifestations | 2 | 1975 | 2 | 0.010 |
Why?
| | Magnoliopsida | 1 | 1978 | 27 | 0.010 |
Why?
| | Regional Health Planning | 1 | 1978 | 7 | 0.010 |
Why?
| | Mitral Valve | 1 | 1979 | 91 | 0.010 |
Why?
| | Beverages | 1 | 1978 | 70 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1987 | 3676 | 0.010 |
Why?
| | Methionine | 1 | 1978 | 145 | 0.010 |
Why?
| | Transportation of Patients | 1 | 1978 | 49 | 0.010 |
Why?
| | Spectrophotometry | 2 | 1976 | 52 | 0.010 |
Why?
| | Heart Valve Prosthesis | 1 | 1979 | 125 | 0.010 |
Why?
| | Clonazepam | 1 | 1977 | 5 | 0.010 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 1976 | 76 | 0.010 |
Why?
| | Citrus | 1 | 1977 | 4 | 0.010 |
Why?
| | Benzodiazepinones | 1 | 1977 | 14 | 0.010 |
Why?
| | Fetal Blood | 1 | 1979 | 270 | 0.010 |
Why?
| | Oils | 1 | 1976 | 19 | 0.010 |
Why?
| | Acetates | 1 | 1977 | 98 | 0.010 |
Why?
| | Models, Chemical | 3 | 1985 | 274 | 0.010 |
Why?
| | Milk | 1 | 1977 | 125 | 0.010 |
Why?
| | Patient Compliance | 1 | 2000 | 532 | 0.010 |
Why?
| | Hypersensitivity | 1 | 1979 | 270 | 0.010 |
Why?
| | Kidney Papillary Necrosis | 1 | 1975 | 1 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 1987 | 4684 | 0.010 |
Why?
| | Pericarditis | 1 | 1975 | 9 | 0.010 |
Why?
| | Agranulocytosis | 1 | 1975 | 31 | 0.010 |
Why?
| | Myoclonus | 1 | 1974 | 11 | 0.010 |
Why?
| | Athetosis | 1 | 1974 | 8 | 0.010 |
Why?
| | Chorea | 1 | 1974 | 12 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1987 | 1795 | 0.010 |
Why?
| | Health Education | 1 | 1978 | 317 | 0.010 |
Why?
| | Levallorphan | 1 | 1974 | 1 | 0.010 |
Why?
| | Nalorphine | 1 | 1974 | 1 | 0.010 |
Why?
| | Heart Block | 1 | 1974 | 37 | 0.010 |
Why?
| | Nitrosourea Compounds | 1 | 1973 | 1 | 0.010 |
Why?
| | Cytochrome Reductases | 1 | 1973 | 3 | 0.010 |
Why?
| | Temperature | 1 | 1977 | 621 | 0.010 |
Why?
| | Hyperkalemia | 1 | 1974 | 24 | 0.010 |
Why?
| | Riboflavin | 1 | 1973 | 7 | 0.010 |
Why?
| | Flavin Mononucleotide | 1 | 1973 | 8 | 0.010 |
Why?
| | Histamine H1 Antagonists | 1 | 1973 | 33 | 0.010 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 1973 | 14 | 0.010 |
Why?
| | Binding Sites | 2 | 1976 | 1221 | 0.010 |
Why?
| | Macaca | 1 | 1973 | 51 | 0.010 |
Why?
| | Water | 1 | 1977 | 422 | 0.010 |
Why?
| | Haplorhini | 1 | 1973 | 62 | 0.010 |
Why?
| | Potassium | 1 | 1974 | 132 | 0.010 |
Why?
| | Mixed Function Oxygenases | 1 | 1973 | 37 | 0.010 |
Why?
| | Heme | 1 | 1973 | 54 | 0.010 |
Why?
| | Drug Tolerance | 1 | 1973 | 78 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1973 | 126 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1973 | 70 | 0.010 |
Why?
| | Antidepressive Agents | 1 | 1974 | 189 | 0.010 |
Why?
| | Methyltransferases | 1 | 1973 | 61 | 0.010 |
Why?
| | Organ Size | 1 | 1973 | 460 | 0.010 |
Why?
| | Phospholipids | 1 | 1973 | 207 | 0.010 |
Why?
| | Suicide | 2 | 1976 | 496 | 0.010 |
Why?
| | NADP | 1 | 1971 | 50 | 0.010 |
Why?
| | Cystic Fibrosis | 1 | 1981 | 963 | 0.010 |
Why?
| | Plants | 1 | 1973 | 209 | 0.010 |
Why?
| | Pre-Eclampsia | 1 | 1973 | 183 | 0.010 |
Why?
| | Safety | 1 | 1993 | 304 | 0.010 |
Why?
| | Chickenpox | 1 | 1972 | 100 | 0.010 |
Why?
| | Glioblastoma | 1 | 1973 | 263 | 0.010 |
Why?
| | Hypoglycemia | 1 | 1975 | 401 | 0.010 |
Why?
| | Body Weight | 1 | 1973 | 923 | 0.010 |
Why?
| | Pulmonary Edema | 2 | 1981 | 119 | 0.010 |
Why?
| | Brain Neoplasms | 2 | 1973 | 1019 | 0.000 |
Why?
| | Hyperkinesis | 1 | 1987 | 11 | 0.000 |
Why?
| | Herpes Zoster | 1 | 1972 | 334 | 0.000 |
Why?
| | Monoamine Oxidase Inhibitors | 1 | 1984 | 15 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1964 | 151 | 0.000 |
Why?
| | Soft Tissue Neoplasms | 1 | 1985 | 92 | 0.000 |
Why?
| | Sarcoma | 1 | 1985 | 137 | 0.000 |
Why?
| | Virulence | 1 | 1964 | 239 | 0.000 |
Why?
| | Structure-Activity Relationship | 1 | 1984 | 522 | 0.000 |
Why?
| | Neuromuscular Diseases | 1 | 1984 | 90 | 0.000 |
Why?
| | Foreign-Body Migration | 1 | 1983 | 37 | 0.000 |
Why?
| | Antineoplastic Agents | 1 | 1973 | 1967 | 0.000 |
Why?
| | Rats, Inbred Strains | 1 | 1981 | 394 | 0.000 |
Why?
| | Infant, Low Birth Weight | 1 | 1981 | 125 | 0.000 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1981 | 178 | 0.000 |
Why?
| | Health Occupations | 1 | 1980 | 30 | 0.000 |
Why?
| | Respiration Disorders | 1 | 1981 | 66 | 0.000 |
Why?
| | Biological Availability | 1 | 1980 | 126 | 0.000 |
Why?
| | Skin Absorption | 1 | 1979 | 12 | 0.000 |
Why?
| | Medicine, Traditional | 1 | 1979 | 23 | 0.000 |
Why?
| | Accidents, Occupational | 1 | 1979 | 14 | 0.000 |
Why?
| | Fires | 1 | 1981 | 74 | 0.000 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1979 | 113 | 0.000 |
Why?
| | Gestational Age | 1 | 1981 | 765 | 0.000 |
Why?
| | Podophyllotoxin | 1 | 1978 | 7 | 0.000 |
Why?
| | Electric Stimulation Therapy | 1 | 1979 | 74 | 0.000 |
Why?
| | Condylomata Acuminata | 1 | 1978 | 7 | 0.000 |
Why?
| | Vulvar Neoplasms | 1 | 1978 | 10 | 0.000 |
Why?
| | Pacemaker, Artificial | 1 | 1979 | 105 | 0.000 |
Why?
| | Heart | 1 | 1982 | 630 | 0.000 |
Why?
| | Shock | 1 | 1979 | 91 | 0.000 |
Why?
| | Administration, Topical | 1 | 1978 | 141 | 0.000 |
Why?
| | Neoplasms | 1 | 1972 | 2160 | 0.000 |
Why?
| | Renal Dialysis | 1 | 1981 | 377 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1976 | 3 | 0.000 |
Why?
| | Vision Disorders | 1 | 1978 | 135 | 0.000 |
Why?
| | Carbon Radioisotopes | 1 | 1976 | 45 | 0.000 |
Why?
| | Mathematics | 1 | 1976 | 103 | 0.000 |
Why?
| | Isotope Labeling | 1 | 1976 | 75 | 0.000 |
Why?
| | Referral and Consultation | 1 | 1980 | 644 | 0.000 |
Why?
| | Quality of Health Care | 1 | 1980 | 585 | 0.000 |
Why?
| | Recurrence | 1 | 1977 | 971 | 0.000 |
Why?
| | Remission, Spontaneous | 1 | 1973 | 37 | 0.000 |
Why?
| | Blood Platelet Disorders | 1 | 1973 | 9 | 0.000 |
Why?
| | Radionuclide Imaging | 1 | 1973 | 124 | 0.000 |
Why?
| | Astrocytoma | 1 | 1973 | 112 | 0.000 |
Why?
| | Dinitrophenols | 1 | 1972 | 7 | 0.000 |
Why?
| | Complement Fixation Tests | 1 | 1972 | 5 | 0.000 |
Why?
| | Immune Sera | 1 | 1972 | 82 | 0.000 |
Why?
| | Splenectomy | 1 | 1972 | 56 | 0.000 |
Why?
| | Medulloblastoma | 1 | 1973 | 177 | 0.000 |
Why?
| | Ependymoma | 1 | 1973 | 165 | 0.000 |
Why?
| | Neoplasm Metastasis | 1 | 1973 | 541 | 0.000 |
Why?
| | Lymphoma | 1 | 1972 | 179 | 0.000 |
Why?
| | Blood Platelets | 1 | 1973 | 344 | 0.000 |
Why?
| | Hodgkin Disease | 1 | 1972 | 119 | 0.000 |
Why?
| | Leukemia | 1 | 1972 | 208 | 0.000 |
Why?
| | Herpesvirus 3, Human | 1 | 1972 | 386 | 0.000 |
Why?
| | Staphylococcal Infections | 1 | 1972 | 348 | 0.000 |
Why?
| | Chronic Disease | 1 | 1973 | 1630 | 0.000 |
Why?
|
|
Rumack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|